Assessing the heart’s function right before decannulation using the surgeon’s eye
Official title: Assessment of Left Ventricular Function Before Decannulation in Cardiopulmonary Bypass Surgeries: Comparison of the Cardiac Surgeon's Visual Estimation and Transesophageal Echocardiography
Run by Ataturk University · NCT07286227 · Data updated 2026-11-12
This study tests how accurately a cardiac surgeon’s quick visual estimate of left ventricular function matches TEE results before removing support after heart surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Ataturk University Academic / other |
| Locations | 1 site (Erzurum) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | December 1, 2026 |
| Study ends | December 2, 2026 |
| Registry record updated | September 4, 2026 |
| Trial ID | NCT07286227 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 undergoing elective CPB-requiring cardiac surgery (CABG, valve, or aortic procedures) with intraoperative TEE eligibility.
✕Probably not a fit
Patients with very poor preoperative LV function or contraindications to TEE may not benefit from visual estimation guidance.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares the cardiovascular surgeon’s visual assessment of left ventricular function before decannulation after cardiopulmonary bypass with the transesophageal echocardiography (TEE) reference standard. The goal is to determine the diagnostic performance of eyeballing LV function in the operating room. Eligible adults undergoing elective cardiac surgery with CPB are included, and intraoperative LV function is assessed visually and then compared to TEE findings. The study aims to clarify whether rapid visual assessment can reliably guide immediate management decisions. TEE remains the reference standard, but visual estimates may offer a faster, bedside appraisal when time is critical.
Why it matters
Potential benefit: If successful, this approach could support quicker, surgeon-driven decisions during CPB decannulation and potentially improve intraoperative efficiency.
How similar studies have gone: Prior work has explored visual estimation versus imaging in cardiology, but direct validation of surgeon eyeballing against TEE in this specific intraoperative context is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 75 years * Scheduled for elective cardiac surgery requiring cardiopulmonary bypass (CABG, valve surgery, or aortic surgery) * ASA physical status III-IV * Able and willing to provide written informed consent * Suitable for intraoperative transesophageal echocardiography (TEE) Exclusion Criteria: * Emergency surgery * Known severe preoperative left ventricular dysfunction (EF \< 30%) * Significant arrhythmias (e.g., atrial fibrillation) * Preoperative requirement for mechanical circulatory support (e.g., IABP) * Contraindications to TEE (esophageal pathology, bleeding risk, strictures) * Inability to provide informed consent
Where it's running
-
Ataturk University
Erzurum, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Muhammed Enes Aydın, Principal Investigator — Ataturk University Department of Anesthesiology and Reanimation
- Study coordinator: Muhammed Enes Aydin, Associate Professor
- Email: enesmd@msn.com
- Phone: +90-554-331-82-89
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can menopausal hormone therapy affect heart function after menopause?
This study tests whether menopausal hormone therapy changes how the heart responds to stress in women who are past menopause.
-
Comparing Biventricular Pacing and Left Bundle Branch Pacing for Heart Failure
This study is testing whether a new way of pacing the heart can help people with heart failure feel better and improve their heart function compared to the standard method.
-
Using Dapagliflozin to Prevent Heart Changes After a Heart Attack
This study tests if the medication dapagliflozin can help prevent heart problems in people who have had a heart attack and have some heart weakness.
-
Improving heart failure treatment for patients who don't respond to standard therapy
This study is testing a new heart treatment using a special device for people with heart failure who haven't felt better with standard therapies, to see if it can improve their heart function and overall health.
-
Detecting heart valve disease and heart failure in a diverse community using cardiac ultrasound
This study is testing if training primary care staff to use quick heart ultrasounds can help find heart valve disease and heart failure earlier in older people from different backgrounds.
-
Investigating heart disease risk factors in psoriasis patients
This study is trying to see if certain heart-related markers can help predict heart disease risk in people with psoriasis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.